drugset
drugset / Trial / NCT03781817

Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures

NCT03781817 ↗

Phase 4 Terminated 40 enrolled University of Alabama at Birmingham
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This a randomized clinical trial involving children with non-operative fractures presenting the emergency department randomized either to intranasal or intravenous ketamine.

Timeline

Start
2019-09-09
Primary completion
2022-01-21
Completion
2022-04-30

Outcome

Outcome not reported

Stopped: “Transition/change of primary investigators”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 1.5 mg/kg Intravenous
Comparator Ketamine Small molecule 9 mg/kg Intravenous

Indications

No indication recorded.